Suchergebnisse - "COVID-19 treatment"

PubPharm (102)

1

Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases

enthalten in: World journal of hepatology | 2021

von Law, M. | Ho, R. | Law, K. | +1

2

MP1032 Treatment in Patients with Moderate to Severe COVID-19 : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PROOF-OF-CONCEPT, PHASE IIA STUDY OF MP1032 PLUS STANDARD OF CARE VS STANDARD OF CARE IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH MODERATE TO SEVERE COVID-19. - MP1032 Treatment in Patients with Moderate to Severe COVID-19

enthalten in: WHO International Clinical Trials Registry Platform | 2021

3

MP1032 Treatment in Patients with Moderate to Severe COVID-19 : A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PROOF-OF-CONCEPT, PHASE IIA STUDY OF MP1032 PLUS STANDARD OF CARE VS STANDARD OF CARE IN THE TREATMENT OF HOSPITALIZED PATIENTS WITH MODERATE TO SEVERE COVID-19. - MP1032 Treatment in Patients with Moderate to Severe COVID-19

enthalten in: WHO International Clinical Trials Registry Platform | 2021

4

Recent advances in low-cost, portable automated resuscitator systems to fight COVID-19

enthalten in: Health and technology | 2021

von Kumar, V. | Kumar, R. | Kumar, M. | +3

5

Recent advances in low-cost, portable automated resuscitator systems to fight COVID-19

enthalten in: Health and Technology | 2021

von Kumar, V. | Kumar, R. | Kumar, M. | +3

6

Recent advances in low-cost, portable automated resuscitator systems to fight COVID-19

enthalten in: Health and Technology | 2021

von Kumar, V. | Kumar, R. | Kumar, M. | +3

7

A study for patients with moderate or severe COVID-19 for the evaluation of the safety and efficacy of a new investigational drug using exosomes : A phase II randomized, single-blind dose study to evaluate the safety and efficacy of exosomes overexpressing CD24 in 10^9 dose versus 10^10 dose, for the prevention of clinical deterioration in patients with moderate or severe COVID-19

enthalten in: WHO International Clinical Trials Registry Platform | 2021

8

A study for patients with moderate or severe COVID-19 for the evaluation of the safety and efficacy of a new investigational drug using exosomes : A phase II randomized, single-blind dose study to evaluate the safety and efficacy of exosomes overexpressing CD24 in 10^9 dose versus 10^10 dose, for the prevention of clinical deterioration in patients with moderate or severe COVID-19

enthalten in: WHO International Clinical Trials Registry Platform | 2021

9

Therapies to Prevent Progression of COVID-19, Including Hydroxychloroquine, Azithromycin, Zinc, and Vitamin D3 With or Without Intravenous Vitamin C : An International, Multicenter, Randomized Trial

enthalten in: Cureus | 2021

von Ried, K. | BinJemain, T. | Sali, A.

10

Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19 : Experience in a Single-Arm Pakistani Center

enthalten in: Cureus | 2021

von Khurshid, S. | Rehman, N. | Ahmed, S. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]